Skip to content

Asymmetric Synthesis Formula Sheet and Short Notes

One-page CSIR NET revision of asymmetric synthesis: ee/de formulas, enantio-discrimination, induction strategies, chiral auxiliaries and resolution.

  • 6 min read
  • Updated
On this page · 7 sections
  1. Enantiomeric and diastereomeric excess
  2. Enantio-discrimination
  3. Substrate-, reagent- and catalyst-controlled induction
  4. Chiral auxiliaries
  5. Optical and kinetic resolution
  6. Last-minute checklist
  7. What’s Next

Every formula, reagent and number from Enantiomeric and Diastereomeric Excess, Enantio-discrimination, Substrate-, Reagent- and Catalyst-Controlled Induction, Chiral Auxiliaries and Optical and Kinetic Resolution, on one page. For the Felkin–Anh and chelation models, use the Stereochemistry quick revision.

Enantiomeric and diastereomeric excess

  • \( \text{ee} = (x_R - x_S)/(x_R + x_S) = 2x - 1 \); \( \text{er} = (1+\text{ee})/(1-\text{ee}) \); \( \text{ee} = (\text{er}-1)/(\text{er}+1) \). Same for de/dr.
  • \( [\alpha] = \alpha_{\text{obs}}/(l\,c) \): l in dm, c in g mL⁻¹; quote λ, T, solvent, c.
  • Optical purity = \( [\alpha]_{\text{obs}}/[\alpha]_{\max} \) = ee only if rotation is linear (Horeau effect = deviation from self-association).
  • \( \Delta\Delta G^\ddagger = RT\ln(\text{er}) \): 5.7 kJ mol⁻¹ per factor 10 at 298 K; 3.7 at 195 K.
  • \( \ln(\text{er}) = \Delta\Delta H^\ddagger/RT - \Delta\Delta S^\ddagger/R \); enthalpic selectivity rises on cooling; isoinversion when the terms cancel.
  • Enantiomers: equilibrium ee = 0, always. Diastereomers: dr = \( e^{-\Delta G^\circ/RT} \).
  • Mixing: signed, amount-weighted average.
  • Duplication (Horeau): dimer ee = \( 2e/(1+e^2) \); meso fraction \( 2pq \). 80% → 97.6%.
eeerΔΔG‡ 298 KΔΔG‡ 195 K
50%32.71.8
80%95.43.6
90%197.34.8
95%399.15.9
98%9911.47.5
99%19913.18.6

Enantio-discrimination

  • Needs a chiral, non-racemic partner (or circularly polarised light). Enantiomer + chiral agent → diastereomeric complexes (different K) or transition states (different k).
  • Three-point model: three contacts needed; Easson–Stedman (drug–receptor), Ogston (aconitase and the enantiotopic arms of citrate).
  • Biology: (R)-carvone spearmint, (S)-carvone caraway; ibuprofen (S) active, (R) partly inverted in vivo; thalidomide racemises in vivo.
  • Chiral HPLC/GC/SFC: polysaccharide, Pirkle, cyclodextrin, protein phases; ee from peak areas; elution order not predictable from R/S.
NMR methodExampleBindingNote
CSAPirkle’s alcoholnon-covalentsmall Δδ
CLSREu(hfc)₃, Eu(tfc)₃Lewis acid to O/Nneeds donor atom; broadening
CDAMTPA (Mosher)covalentcomplete conversion needed
  • MTPA: Ph–C(OMe)(CF₃)–COOH; no α-H (no racemisation). (R)-MTPA-Cl → (S)-MTPA ester (COCl outranks CF₃; CO₂R does not).
  • Advanced Mosher: Δδ = δS − δR on each side of the carbinol carbon → absolute configuration.
  • Impure agent: de(obs) = ee(analyte) × ee(agent); racemic agent → always 1:1.
  • Chiroptical: rotation/ORD (birefringence), CD (\( \Delta\varepsilon = \varepsilon_L - \varepsilon_R \)), Cotton effect, VCD.
  • Enantiotopic protons equivalent in CDCl₃; diastereotopic not.

Substrate-, reagent- and catalyst-controlled induction

GenerationChiral elementProductsMeasured as
1 Substratestereocentre in substratediastereomersdr
2 Auxiliaryattached, removeddiastereomers → enantiomersdr → ee
3 Reagentstoichiometric chiral reagentenantiomersee
4 Catalystsubstoichiometricenantiomersee
  • Substrate control: convex face, exo norbornene, α-face steroids; Felkin–Anh, chelation, 1,3-induction, directed epoxidation; chirality transfer (Ireland–Claisen, [2,3]-Wittig).
  • Reagents: Ipc₂BH (cis-alkenes); IpcBH₂ (trans, trisubstituted); Alpine-Borane (acetylenic ketones); DIP-Cl (aryl alkyl ketones); BINAL-H (π-substituted ketones); chiral lithium amides, s-BuLi/(−)-sparteine.
  • Crotylboration: E → anti, Z → syn; ligand → absolute configuration; four reagents → four stereoisomers.
  • Catalysts: Rh–DIPAMP, Ru–BINAP, Ti–DET (SAE), Os–cinchona (AD), Mn–salen, Cu–BOX, CBS, proline (enamine), MacMillan (iminium), thioureas, chiral phosphoric acids, cinchonium PTC, enzymes (baker’s yeast).
  • C₂ symmetry halves competing TSs. Ligand acceleration beats background; background dilutes: ee(obs) = ee(cat) × f(cat).
  • Linear: ee(P) = ee(max) × ee(cat). Positive NLE = amplification (heterochiral reservoir).
  • Double induction: matched = dr(sub) × dr(reag); mismatched = dr(reag)/dr(sub). 3:1 and 30:1 → 90:1 and 10:1.

Chiral auxiliaries

  • Cycle: attach → diastereoselective step → purify → cleave → recover.
AuxiliarySourceSelective stepCleavage
Evans oxazolidinonevalinol, phenylalaninol, norephedrinechelated Z-enolate alkylation; Bu₂BOTf boron aldol → Evans synLiOOH (acid), LiBH₄ (alcohol), alkoxide, Weinreb
Oppolzer sultamcamphoralkylation, aldol, Diels–AlderLiOOH, hydride
SAMP/RAMP(S)-proline / enantiomerazaenolate alkylation of ketones/aldehydesO₃ or MeI/H₃O⁺
MyerspseudoephedrineLDA/LiCl amide enolate alkylationhydrolysis, reduction, RLi
Ellmant-BuS(O)NH₂, S-stereogenicRMgX to N-sulfinyl iminesHCl/MeOH → amines
8-PhenylmentholmentholDiels–Alder of acrylatesester cleavage
Seebach SRSsubstrate itselfpivalaldehyde acetal; enolate alkylationacetal hydrolysis
  • Evans: Z-enolate decides syn; C4 group decides face; boron cannot chelate (dipole-minimised); chelating conditions → non-Evans syn.
  • Arithmetic: overall yield = product of step yields; ee(crude) = a × de; ee(purified) = a (auxiliary ee is the ceiling).

Optical and kinetic resolution

  • Conglomerate (separate crystals; Pasteur, preferential crystallisation, Viedma ripening) / racemic compound (most common) / pseudoracemate (solid solution).
  • Salts: acids by brucine, strychnine, quinine, cinchonidine, 1-phenylethylamine; bases by tartaric, dibenzoyltartaric, camphorsulfonic, mandelic acids; neutral alcohols via half-esters.
  • RRR: 50 + 25 + 12.5 = 87.5% after three ideal cycles.
  • Kagan: \( s = \ln[(1-c)(1-\text{ee}_{SM})]/\ln[(1-c)(1+\text{ee}_{SM})] \); mass balance \( c\,\text{ee}_P = (1-c)\,\text{ee}_{SM} \).
  • c for 99% ee(SM): \( \ln(1-c) = [\ln(1-\text{ee}) - s\ln(1+\text{ee})]/(s-1) \).
see at c = 50%c for 99% ee(SM)
551%87%
1067%72%
2079%62%
5089%55%
  • ee(SM) rises with c; ee(P) falls, starting from (s − 1)/(s + 1).
  • KR tools: lipases + vinyl acetate (Kazlauskas rule), SAE of secondary allylic alcohols, Jacobsen HKR of terminal epoxides, acylase I for N-acetyl amino acids.
  • Parallel KR: both enantiomers → different products.
  • DKR: fast racemisation; 100%; ee = (s − 1)/(s + 1) constant; Noyori β-keto ester hydrogenation; lipase + Ru (Bäckvall).
  • Deracemisation: same compound, one enantiomer. Desymmetrisation: meso/prochiral, 100% (PLE, lipases, chiral lithium amides).

Last-minute checklist

If the question gives…Do this
a composition or HPLC areasee = (a − b)/(a + b)
a rotationop = [α]/[α]max, then x = (1 + ee)/2
an ee and a temperatureer, then RT ln er
two chiral partnersmatched ×, mismatched ÷
a derivatising agent of < 100% eetrue ee = de(obs)/ee(agent)
an auxiliary of < 100% eeproduct ee ≤ auxiliary ee
conversion and ee in a resolutionKagan equation + mass balance

What’s Next

Return to the Asymmetric Synthesis overview, revisit Principles of Stereochemistry, or continue to Homogeneous Catalysis for the organometallic side of asymmetric hydrogenation.

Advertisement
Advertisement